1. Home
  2. NRSN vs PLAG Comparison

NRSN vs PLAG Comparison

Compare NRSN & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • PLAG
  • Stock Information
  • Founded
  • NRSN 2017
  • PLAG 1986
  • Country
  • NRSN Israel
  • PLAG United States
  • Employees
  • NRSN N/A
  • PLAG N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • PLAG Packaged Foods
  • Sector
  • NRSN Health Care
  • PLAG Consumer Staples
  • Exchange
  • NRSN Nasdaq
  • PLAG Nasdaq
  • Market Cap
  • NRSN 17.8M
  • PLAG 18.9M
  • IPO Year
  • NRSN 2021
  • PLAG N/A
  • Fundamental
  • Price
  • NRSN $1.12
  • PLAG $2.07
  • Analyst Decision
  • NRSN Hold
  • PLAG
  • Analyst Count
  • NRSN 1
  • PLAG 0
  • Target Price
  • NRSN N/A
  • PLAG N/A
  • AVG Volume (30 Days)
  • NRSN 129.6K
  • PLAG 28.3K
  • Earning Date
  • NRSN 04-04-2025
  • PLAG 03-31-2025
  • Dividend Yield
  • NRSN N/A
  • PLAG N/A
  • EPS Growth
  • NRSN N/A
  • PLAG N/A
  • EPS
  • NRSN N/A
  • PLAG N/A
  • Revenue
  • NRSN N/A
  • PLAG $16,965,260.00
  • Revenue This Year
  • NRSN N/A
  • PLAG N/A
  • Revenue Next Year
  • NRSN N/A
  • PLAG N/A
  • P/E Ratio
  • NRSN N/A
  • PLAG N/A
  • Revenue Growth
  • NRSN N/A
  • PLAG N/A
  • 52 Week Low
  • NRSN $0.51
  • PLAG $1.18
  • 52 Week High
  • NRSN $2.25
  • PLAG $5.52
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 51.47
  • PLAG 47.22
  • Support Level
  • NRSN $0.96
  • PLAG $1.82
  • Resistance Level
  • NRSN $1.17
  • PLAG $2.31
  • Average True Range (ATR)
  • NRSN 0.08
  • PLAG 0.25
  • MACD
  • NRSN 0.00
  • PLAG 0.01
  • Stochastic Oscillator
  • NRSN 66.24
  • PLAG 44.16

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

Share on Social Networks: